Doubts About Stroma-Targeting Agents in Pancreatic Cancer Doubts About Stroma-Targeting Agents in Pancreatic Cancer

Adding pegvorhyaluronidase alfa to treatment with nab-paclitaxel and gemcitabine did not improve survival in adults with previously untreated metastatic pancreatic ductal adenocarcinoma in a phase 3 trial.Medscape Medical News

Source: Medscape Hematology-Oncology Headlines - August 3, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news